Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia

Iron chelation therapy (ICT) is the mainstay of treatment in patients with thalassemia requiring blood transfusions. This phase 2 JUPITER study evaluated patient preference between film-coated tablet (FCT) and dispersible tablet (DT) in transfusion-dependent thalassemia (TDT) or non-TDT (NTDT) patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Viprakasit, Vip, Hamdy, Mona M., Hassab, Hoda M. A., Sherief, Laila M., Al-Bagshi, Muneer, Khattab, Mohammed, Chuncharunee, Suporn, Dung, Phu Chi, Küpesiz, Alphan, Shekhawat, Ankita, Sonawane, Yamini, Perez, Laura Torres, Slader, Cassandra, Taher, Ali T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209569/
https://www.ncbi.nlm.nih.gov/pubmed/37227493
http://dx.doi.org/10.1007/s00277-023-05240-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209569/
https://www.ncbi.nlm.nih.gov/pubmed/37227493
http://dx.doi.org/10.1007/s00277-023-05240-3

Ejemplares similares